Invention Grant
US09534034B2 Methods of modulating apoptosis by administration of relaxin agonists or antagonists
有权
通过施用松弛素激动剂或拮抗剂调节凋亡的方法
- Patent Title: Methods of modulating apoptosis by administration of relaxin agonists or antagonists
- Patent Title (中): 通过施用松弛素激动剂或拮抗剂调节凋亡的方法
-
Application No.: US13399620Application Date: 2012-02-17
-
Publication No.: US09534034B2Publication Date: 2017-01-03
- Inventor: Edward P. Amento , Chrishan S. Samuel
- Applicant: Edward P. Amento , Chrishan S. Samuel
- Applicant Address: US CA Sunnyvale
- Assignee: Molecular Medicine Research Institute
- Current Assignee: Molecular Medicine Research Institute
- Current Assignee Address: US CA Sunnyvale
- Agency: Christensen O'Connor Johnson Kindness PLLC
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K14/64 ; A01K67/027 ; A61K38/22
Abstract:
The present invention relates to the discovery that relaxin is associated with the development or maturation of body tissues. Knockouts of the gene encoding relaxin result in various abnormalities in the development of various tissues. The present invention provides methods of modulating apoptosis by administering a relaxin agonist or antagonist to a subject.
Public/Granted literature
- US20120238499A1 METHODS OF MODULATING APOPTOSIS BY ADMINISTRATION OF RELAXIN AGONISTS OR ANTAGONISTS Public/Granted day:2012-09-20
Information query
IPC分类:
